Amalgamated Bank’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
Amalgamated Bank's AMPH Position: Q1 2026 in Review
Amalgamated Bank reduced its Amphastar Pharmaceuticals (AMPH) stake by 2% in Q1 2026, selling an estimated $4.99K and leaving 10,215 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #1563.
Amalgamated Bank first reported a position in AMPH in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.01M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- Amalgamated Bank held 10,215 shares of Amphastar Pharmaceuticals worth $200K as of Q1 2026.
- Amalgamated Bank sold 204 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $4.99K.
- Amphastar Pharmaceuticals made up ﹤0.01% of Amalgamated Bank's portfolio in Q1 2026, its #1563 holding.
- Amalgamated Bank first reported a position in Amphastar Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
- Amalgamated Bank's Amphastar Pharmaceuticals position peaked at $1.01M in Q4 2023.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.